OTC •
Healthcare •
Biotechnology •
Quote as of 10/28/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.03 mln
Float36.96 mln
Relative Strength
1
/ 100
Severely lagging
Pre-Tax Margin
-1,211%
Severely loss-making
ROE
112
Extraordinary
ROA
-229
Deeply negative
Business Description
Affymax Inc. is a New York-based company founded in 2001 that no longer carries out meaningful business activity. It formerly worked on medications aimed at helping patients in the United States manage severe and potentially fatal illnesses.